BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4526571)

  • 1. [Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy].
    Saggese V; Zanda G
    Minerva Pediatr; 1974 Jun; 26(21):1087-93. PubMed ID: 4526571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
    Mathe G; Amiel JL; Schwarsenberg L; Hyat M; Pouillart P; Schenider M; Cattan A; Jasmin C; Belpomme D; Schulmberger JR; De Vassal F; Musset M; Misset JL
    Folia Clin Int (Barc); 1975 Mar; 25(3):131-51. PubMed ID: 1056311
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of lung cancer].
    Jassem J; Jassem E
    Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy in previously treated acute lymphatic leukemia.
    Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
    Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunotherapy of cancer: evolution of concepts and clinical advances].
    Baldwin RW
    Rev Prat; 1980 Jan; 30(5):221-4, 227-8. PubMed ID: 6929557
    [No Abstract]   [Full Text] [Related]  

  • 6. New experimental and clinical data on leukaemia immunotherapy.
    Mathé G; Schwarzenberg L; Amiel JL; Pouillart P; Hayat M; de Vassal F; Rosenfeld C; Jasmin C
    Proc R Soc Med; 1975 Apr; 68(4):211-6. PubMed ID: 1060146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [BCG immunotherapy in children with acute lymphocytic leukemia in continuous remission after 3 years of intensive chemotherapy (protocol C-70) (author's transl)].
    Ortega JJ; Javier G
    Med Clin (Barc); 1982 Mar 1-15; 78(5):183-8. PubMed ID: 6952060
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of the acute leukemias.
    Bernard J; Jacquillat C; Weil M
    Semin Hematol; 1972 Apr; 9(2):181-91. PubMed ID: 4553226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemoimmunotherapy of acute lymphoid leukemia in children].
    Eremeev VS; Rumiantsev AG; Akimova GV; Osipov SG; Kisliak NS
    Sov Med; 1980; (2):54-7. PubMed ID: 6928729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical therapy of neoplastic disease. Polychemotherapy and aspecific, active immunostimulation].
    Saccani F; Becchi G
    Minerva Med; 1973 Jan; 64(2):71-5. PubMed ID: 4687731
    [No Abstract]   [Full Text] [Related]  

  • 11. Results in children of acute lymphoid leukemia: protocol ICIG-ALL 9 consisting of chemotherapy for only 9 months followed by active immunotherapy: comparison with the results of more prolonged chemotherapy protocols. Recognition of two groups of acute lymphoid leukemias from prognostic parameters.
    Mathé G; De Vassal F; Schwarzenberg L; Gil MA; Delgado M; Weiner R; Pena-Angulo J; Belpomme D; Pouillart P; Machover D; Misset JL; Pico JL; Jasmin C; Hayat M; Schneider M; Cattan A; Amiel JL; Musset M; Rosenfeld C
    Recent Results Cancer Res; 1977; (62):67-77. PubMed ID: 341251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of the treatment of infantile acute leukemias].
    Răuţa I
    Rev Med Chir Soc Med Nat Iasi; 1972; 76(4):871-82. PubMed ID: 4347955
    [No Abstract]   [Full Text] [Related]  

  • 13. [BCG and irradiated allogenic blast cells in maintenance chemotherapy of children with acute lymphoblastic leukemia in remission. A controlled study].
    Ortega JJ; Javier G
    Sangre (Barc); 1982; 27(3):349-57. PubMed ID: 6760428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of 3 protocols of treatment of acute lymphoid leukemia in children].
    Mathé G; de Vassal F; Schwarzenberg L; Delgado M; Weiner R; Gil MA; Pena-Angulo J; Belpomme D; Pouillart P; Machover D; Misset JL; Pico JL; Jasmin C; Hayat M; Schneider M; Cattan A; Amiel JL; Musset M; Rosenfeld C; Ribaud P
    Arch Fr Pediatr; 1977; 34(7):611-21. PubMed ID: 270966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
    Mathé G
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):881-3. PubMed ID: 5304470
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term remission in acute lymphoid leukemia patients on maintenance chemoimmunotherapy.
    Eremeev VS; Rumyantsev AG; Akimova GV; Osipov SG; Kislyak NS; Bergolz VM
    Neoplasma; 1981; 28(2):219-21. PubMed ID: 6942239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
    Mathe G
    Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current trends in immunotherapy of tumors of the lung].
    Crispano G; Toglia V; Tranchese D; Schettini R
    Arch Monaldi; 1983; 38(1-2):41-52. PubMed ID: 6675558
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of chemotherapy, radiotherapy and immunotherapy for acute lymphoblastic leukemia in children.
    Suvatte V; Mahasandana C; Tanphaichitr VS; Tuchinda S; Vootiprux V
    J Med Assoc Thai; 1981 Apr; 64(4):180-91. PubMed ID: 6942080
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of immunotherapy in acute myelogenous leukemia.
    Foon KA; Smalley RV; Riggs CW; Gale RP
    Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.